MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Masticatory function evaluation methods in movement disorders

Y. Navarrete Cortés, P. Castelo, L. Feitosa, G. Azevedo Diaféria, A. Said, C. Ribeiro Neves, O. Barsottini, S. Bommarito (São Paulo, Brazil)

Meeting: 2024 International Congress

Abstract Number: 539

Keywords: Dysphagia, Parkinson’s, Spinocerebellar ataxia

Category: Physical Therapy, Speech Therapy, Rehabilitation

Objective: To characterize masticatory function in individuals with Parkinson’s Disease (PD) and Spinocerebellar Ataxia (SCA3) regarding the orofacial myofunctional condition (OMES-E), the masticatory performance and facial thermal profile.

Background: The goal of speech therapy for neurological diseases is to adjust, adapt or promote the maintenance of stomatognathic functions, especially in movement disorders. Within this group of diseases, we find PD and SCA3, diseases with similar symptoms characterized by the degenerative process. Although there are different methods to evaluate the masticatory function, there is still little literature on SCA3, therefore, in this study, the masticatory function was characterized in SCA3 and PD, applying the methods of facial thermal profile and color-changeable chewing gum.

Method: 72 individuals of both sexes were evaluated, distributed in two groups: Experimental Group: PD group (30 individuals) and SCA3 group (15 individuals); and Control group, composed of healthy individuals. All participants were evaluated and subjected to the following procedures: facial thermal profile [figure1], masticatory performance [figure2] and Expanded Protocol of Orofacial Myofunctional Evaluation with Scores (OMES-E).

Results: The mean age in the PD group was 67 years and in the SCA3 it was 46 years, and the prevalence of sex in the PD was male and in the SCA3 and in the control group it was female. In the facial thermal profile, the control group showed higher values compared to the PD group in the minimum temperature of the left temporal (p=0.021) and in the minimum temperature of the right masseter muscle (p=0.044). As for masticatory performance, the groups obtained statistically similar data, but when analyzing the masticatory strokes, it was observed that the control group presented higher values with 41 chewing strokes, followed by the PD group with 38 chewing strokes and the SCA3 group with 37 chewing strokes per minute. Finally, in OMES-E, it was observed that the control group presented higher values, followed by the PD and SCA3 groups in the variables posture/position and mobility of myofunctional structures, stomatognathic functions of swallowing and mastication, and the total score of the protocol.

Conclusion: SCA3 and PD present altered muscular condition, although SCA3 displays worse orofacial muscular condition, masticatory function, and facial thermal condition compared to DP.

Figure 1. Facial thermal profile

Figure 1. Facial thermal profile

Figure 2. Masticatory Performance

Figure 2. Masticatory Performance

To cite this abstract in AMA style:

Y. Navarrete Cortés, P. Castelo, L. Feitosa, G. Azevedo Diaféria, A. Said, C. Ribeiro Neves, O. Barsottini, S. Bommarito. Masticatory function evaluation methods in movement disorders [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/masticatory-function-evaluation-methods-in-movement-disorders/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/masticatory-function-evaluation-methods-in-movement-disorders/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley